161 Development of a CD8 co-receptor independent T cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T cell-based immunotherapy

• Daniel Sommermeyer,
• Christian Ellinger,
• Giulia Longinotti,
• Dolores Schendel,
• Kathrin Davari,
• Tristan Holland,
• Laura Prassmayer,
• Kenneth Ganley,
• Lisa Pechilis,
• Iulia Diaconu,
• Prashant Nambiar,
• Mike Magee,
• Rer Nat

Affiliations

Daniel Sommermeyer

Aff1 grid.34477.330000000122986657Fred Hutchinson Cancer Research CenterUniversity of Washington Seattle WA USA

Christian Ellinger

Aff1 Trianta Immunotherapies GmbH - a subsidiary of Medigene AG Germany

Giulia Longinotti

Aff1 Trianta Immunotherapies GmbH - a subsidiary of Medigene AG Germany

Dolores Schendel

3Medigene AG, Planegg-Martinsried, Germany

Kathrin Davari

1Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany

Tristan Holland

1Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany

Laura Prassmayer

1Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany

Kenneth Ganley

2Bluebird Bio Inc., Cambridge, MA, USA

Lisa Pechilis

2Bluebird Bio Inc., Cambridge, MA, USA

Iulia Diaconu

2Bluebird Bio Inc., Cambridge, MA, USA

Prashant Nambiar

2Bluebird Bio Inc., Cambridge, MA, USA

Mike Magee

2Bluebird Bio Inc., Cambridge, MA, USA

Rer Nat

1Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany